Filing Details
- Accession Number:
- 0001140361-13-011894
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-11 21:45:48
- Reporting Period:
- 2013-03-06
- Filing Date:
- 2013-03-11
- Accepted Time:
- 2013-03-11 21:45:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1379006 | Nanoviricides Inc. | NNVC.OB | Services-Commercial Physical & Biological Research (8731) | 760674577 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1505292 | Eugene Seymour | 135 Wood Street West Haven CT 06516 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-06 | 25,000 | $0.69 | 6,025,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Does not include 500,000 shares of NanoViricides common stock issuable upon exercise of options held by Dr. Seymour that are currently exercisable or will become exercisable within 60 days.